year
Details for 4-(5-(3-chloro-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-1-naphthoic acid
Category: | Pharmaceuticals and Biochemicals |
|
|
CAS NO: | 1308362-48-2 | ||
EC NO: | |||
Molecular Formula: | |||
Molecular Weight: | 487.78 | ||
Specification: | 1kg/5kg/25kg | ||
Packing: | Bag/Barrel | ||
Product description: Product name:4-(5-(3-chloro-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-1-naphthoic acid chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]naphthalene-1-carboxylicacid ( Afoxolanerintermediate);afoxolaner-012;afoxolanerImpurity15 CAS No. 1308362-48-2 Molecular Formula: C22 H12 Cl F6 N O3 Molecular weight: 487.78 Properties: white powder Application: Used as Aflana intermediate Product specification: 1kg/barrel, 2kg/barrel, 5kg/barrel, 10kg/barrel, 15kg/barrel, 20kg/barrel, 25kg/barrel, etc. Packing is subject to actual conditions, and can be sub-packed according to customers' requirements. Price: Price is for reference only, call us for one-to-one quotation. Advantageous products Main products: Vonorazan fumarate and its intermediates, Dagliflozin and its intermediates, Cliborol and its intermediates, Letemovir and its intermediates, Rasmeterol and its intermediates, Mildronate, Veterinary products (intermediates of Floreana, Gamifenacin, Lotilana, Aphrodisiac, and Sarolana, etc.), Ropivacaine Hydrochloride and its intermediates, Local anesthesia series (Lidocaine Hydrochloride, Lidocaine Procainamide hydrochloride, Procainamide hydrochloride, Bupivacaine hydrochloride, etc.), covering local anesthetics, antiviral drugs, cardiovascular and cerebrovascular drugs, antitumor drugs, digestive drugs, diabetes drugs, veterinary drugs and other fields. Our main advantages are high quality products, reasonable price, fast delivery and considerate after-sales service, and we support customized products. |
|||
Uses: | Used as Aflana intermediate | ||
Molecular Structure: |
![]() |